Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>FLT3+ *** > Treatment > JP. A. Gilteritinib>



JP. A. Gilteritinib>'s subsections
(*) EU Approval Date: 2019. 10.25.
(*) JP Approval Date: ?
(*) USA Approval Date: 2018. 11.29.
>Relapsed/Refractory
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA/WO No.: 3
Patent>UpDate: 2018. 11.27.
TradeMark
TradeMark Web-Site

JP. A. Gilteritinib>'s products
This section has no products